Hard-caution tier / IV + injectable
NAD Injection and IV NAD+ in the Research Literature
The route with the thinnest controlled evidence, read straight: what the pharmacokinetics show, why infused NAD+ disappears from plasma fast, and the documented quality risk.
The short version
A NAD injection delivers NAD+ (the cell's fuel-handling coenzyme) directly into the body, usually as an intravenous (IV) drip or a shot. Of the three ways NAD+ is sold, NAD injection and IV NAD+ have the least controlled evidence behind them. Injectable and IV NAD+ is a compounded wellness therapy - mixed by a compounding pharmacy, not an FDA-approved product. The pharmacokinetics are unflattering: infused NAD+ is rapidly cleared from the blood, so little intact NAD+ stays around. And there is a documented quality risk - a compounded injectable NAD+ product was recalled at the FDA's most serious level for contamination. This page reads that record without selling anything.
What an NAD injection is
An NAD injection delivers NAD+ parenterally - bypassing the gut by IV infusion or by subcutaneous or intramuscular shot. The appeal is intuitive: if oral NAD+ is poorly absorbed, deliver it directly. The evidence does not reward the intuition cleanly. IV and injectable NAD+ is compounded, not FDA-approved, and the controlled data are limited to pilot and retrospective accounts [16]. The mechanistic claims ride on the same biology as the oral side - NAD+ feeding redox metabolism and the sirtuins-PARP-CD38 axis [5] - but the delivery question (does infused NAD+ actually reach cells intact?) is answered separately, and not in IV NAD+'s favor.
Clearance and persistence in the research
Infused NAD+ does not linger in plasma. A pilot pharmacokinetic study of IV NAD+ found the molecule is extensively metabolized extracellularly and rapidly cleared - near-complete plasma removal within roughly the first two hours of infusion [16]. That is the central pharmacokinetic fact behind IV NAD+: the intact coenzyme is largely gone from the blood quickly, with little evidence of substantial intact cellular uptake [16]. It contrasts directly with oral precursors, which raise whole-blood NAD+ over days to weeks and sustain the elevation through chronic dosing [4]. On the question of an NAD+ half-life, there is no clean single number for intact NAD+ in humans - what the data show is rapid plasma clearance of infused NAD+ on one hand, and a slow days-to-weeks rise in blood NAD+ from oral precursors on the other [16][4].
The documented quality risk
Compounded injectables carry a contamination risk that oral capsules do not, and NAD+ has a concrete example on the record: the FDA issued a Class I recall - its most serious category, reserved for products that could cause serious harm or death - of a compounded NAD+ injection over elevated bacterial endotoxin [16]. Separately, IV NAD+ infusions can provoke chest or abdominal discomfort, flushing and nausea when run too quickly, with the symptoms resolving once the infusion stops [16]. Reconstituted injectable NAD+ also degrades and should be kept cold and protected from light [16]. These are buyer-beware facts about an unapproved compounded product, not approval-grade safety data.
Where the controlled evidence actually is
The strongest human NAD+ evidence is oral, not injected. Randomized trials of oral NMN and NR reliably and dose-dependently raise blood NAD+ - NR by 22%/51%/142% at 100/300/1000 mg/day over eight weeks [4], NMN across all doses from 300-900 mg/day over 60 days [3] - and one NMN trial reported improved muscle insulin sensitivity at 250 mg/day [1]. IV NAD+ has no comparable body of controlled efficacy data; its case rests on minimal controlled evidence against a pharmacokinetic profile of rapid clearance [16]. For the precursor side of the comparison, see NMN vs NR; for how each finding is graded, see tolerability and safety.
What is an NAD injection?
An NAD injection delivers NAD+ parenterally - into the body by IV infusion or by a subcutaneous or intramuscular shot. Injectable and IV NAD+ is a compounded wellness therapy, not an FDA-approved product, and it carries documented quality risks, including an FDA Class I recall of a compounded NAD+ injection for endotoxin contamination [16].
Is NAD+ shot worth it?
The controlled evidence for IV or injectable NAD+ is weak. A pilot pharmacokinetic study found infused NAD+ is rapidly cleared from plasma with little intact uptake, and the route rests on minimal controlled efficacy data [16]. That is research framing, not an endorsement; whether any product is worthwhile is a clinician's call, not this site's.
Does NAD IV actually work?
On pharmacokinetics, a pilot study showed infused NAD+ is extensively metabolized extracellularly and cleared from plasma quickly, so little intact NAD+ persists [16]. Controlled efficacy data for IV NAD+ are limited. The strongest human NAD+ evidence is for oral precursors that raise blood NAD+, not for IV infusion [4][3].
When should you inject NAD+?
The studies do not establish an injection timing or schedule. Reported wellness protocols use multi-hour infusions, but no controlled trial defines an optimal time or frequency [16]. This page reports what the research measured and gives no instruction to inject NAD+ at any time.